{"database": "lobbying", "table": "lobbying_activities", "rows": [[2260523, "d5a9606a-9e59-4e82-9390-75ace304f97f", "1T", "BROWN RUDNICK LLP", 287895, "PRIME THERAPEUTICS", 2019, "first_quarter", "HCR", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2019-02-08T15:13:13.777000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2260523"], "units": {}, "query_ms": 0.20104809664189816, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}